Tags

Type your tag names separated by a space and hit enter

Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model.
Hum Vaccin Immunother. 2021 08 03; 17(8):2378-2388.HV

Abstract

Background: Vaccine hesitancy has been recognized as an urgent public health issue. We aimed to explore the acceptance of a COVID-19 vaccine and related factors among pregnant women, a vulnerable population for vaccine-preventable diseases.Methods: A multi-center cross-sectional study among pregnant women was conducted in five provinces of mainland China from November 13 to 27, 2020. We collected sociodemographic characteristics, attitude, knowledge, and health beliefs on COVID-19 vaccination. Locally weighted scatterplot smoothing regression analysis was used to assess the trends of vaccination acceptance. Multivariable logistic regression was performed to identify factors related to vaccination acceptance.Results: Among the 1392 pregnant women, the acceptance rate of a COVID-19 vaccine were 77.4% (95%CI 75.1-79.5%). In the multivariable regression model, the acceptance rate was associated with young age (aOR = 1.87, 95% CI: 1.20-2.93), western region (aOR = 2.73, 95% CI: 1.72-4.32), low level of education (aOR = 2.49, 95% CI: 1.13-5.51), late pregnancy (aOR = 1.49, 95% CI: 1.03-2.16), high knowledge score on COVID-19 (aOR = 1.05, 95% CI: 1.01-1.10), high level of perceived susceptibility (aOR = 2.18, 95% CI: 1.36-3.49), low level of perceived barriers (aOR = 4.76, 95% CI: 2.23-10.18), high level of perceived benefit (aOR = 2.18, 95% CI: 1.36-3.49), and high level of perceived cues to action (aOR = 15.70, 95% CI: 8.28-29.80).Conclusions: About one quarters of pregnant women have vaccine hesitancy. Our findings highlight that targeted and multipronged efforts are needed to build vaccine literacy and confidence to increase the acceptance of a COVID-19 vaccine during the COVID-19 pandemic, especially for vulnerable populations.

Authors+Show Affiliations

Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.Department of Obstetrics, Tongzhou Maternal and Child Health Hospital, Beijing, China.Department of Obstetrics, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China.Department of Obstetrics, Qianjiang Maternal and Child Health Hospital, Qianjiang City, Hubei Province, China.Department of Obstetrics, Qianjiang Central Hospital, Qianjiang City, Hubei Province, China.Department of Obstetrics, Qujing Maternal and Child Health Hospital, Qujing City, Yunnan Province, China.Department of Obstetrics, Shexian Maternal and Child Health Hospital, Shexian City, Hebei Province, China.Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China. National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.

Pub Type(s)

Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

33989109

Citation

Tao, Liyuan, et al. "Acceptance of a COVID-19 Vaccine and Associated Factors Among Pregnant Women in China: a Multi-center Cross-sectional Study Based On Health Belief Model." Human Vaccines & Immunotherapeutics, vol. 17, no. 8, 2021, pp. 2378-2388.
Tao L, Wang R, Han N, et al. Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model. Hum Vaccin Immunother. 2021;17(8):2378-2388.
Tao, L., Wang, R., Han, N., Liu, J., Yuan, C., Deng, L., Han, C., Sun, F., Liu, M., & Liu, J. (2021). Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model. Human Vaccines & Immunotherapeutics, 17(8), 2378-2388. https://doi.org/10.1080/21645515.2021.1892432
Tao L, et al. Acceptance of a COVID-19 Vaccine and Associated Factors Among Pregnant Women in China: a Multi-center Cross-sectional Study Based On Health Belief Model. Hum Vaccin Immunother. 2021 08 3;17(8):2378-2388. PubMed PMID: 33989109.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model. AU - Tao,Liyuan, AU - Wang,Ruitong, AU - Han,Na, AU - Liu,Jihong, AU - Yuan,Chuanxiang, AU - Deng,Lixia, AU - Han,Chunhua, AU - Sun,Fenglan, AU - Liu,Min, AU - Liu,Jue, Y1 - 2021/05/14/ PY - 2021/5/15/pubmed PY - 2021/9/30/medline PY - 2021/5/14/entrez KW - COVID-19 KW - acceptance KW - pregnant women KW - vaccine KW - vaccine hesitancy SP - 2378 EP - 2388 JF - Human vaccines & immunotherapeutics JO - Hum Vaccin Immunother VL - 17 IS - 8 N2 - Background: Vaccine hesitancy has been recognized as an urgent public health issue. We aimed to explore the acceptance of a COVID-19 vaccine and related factors among pregnant women, a vulnerable population for vaccine-preventable diseases.Methods: A multi-center cross-sectional study among pregnant women was conducted in five provinces of mainland China from November 13 to 27, 2020. We collected sociodemographic characteristics, attitude, knowledge, and health beliefs on COVID-19 vaccination. Locally weighted scatterplot smoothing regression analysis was used to assess the trends of vaccination acceptance. Multivariable logistic regression was performed to identify factors related to vaccination acceptance.Results: Among the 1392 pregnant women, the acceptance rate of a COVID-19 vaccine were 77.4% (95%CI 75.1-79.5%). In the multivariable regression model, the acceptance rate was associated with young age (aOR = 1.87, 95% CI: 1.20-2.93), western region (aOR = 2.73, 95% CI: 1.72-4.32), low level of education (aOR = 2.49, 95% CI: 1.13-5.51), late pregnancy (aOR = 1.49, 95% CI: 1.03-2.16), high knowledge score on COVID-19 (aOR = 1.05, 95% CI: 1.01-1.10), high level of perceived susceptibility (aOR = 2.18, 95% CI: 1.36-3.49), low level of perceived barriers (aOR = 4.76, 95% CI: 2.23-10.18), high level of perceived benefit (aOR = 2.18, 95% CI: 1.36-3.49), and high level of perceived cues to action (aOR = 15.70, 95% CI: 8.28-29.80).Conclusions: About one quarters of pregnant women have vaccine hesitancy. Our findings highlight that targeted and multipronged efforts are needed to build vaccine literacy and confidence to increase the acceptance of a COVID-19 vaccine during the COVID-19 pandemic, especially for vulnerable populations. SN - 2164-554X UR - https://www.unboundmedicine.com/medline/citation/33989109/Acceptance_of_a_COVID_19_vaccine_and_associated_factors_among_pregnant_women_in_China:_a_multi_center_cross_sectional_study_based_on_health_belief_model_ DB - PRIME DP - Unbound Medicine ER -